Research Article

Regulation of Daily Locomotor Activity and Sleep by Hypothalamic EGF Receptor Signaling

See allHide authors and affiliations

Science  21 Dec 2001:
Vol. 294, Issue 5551, pp. 2511-2515
DOI: 10.1126/science.1067716

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

The circadian clock in the suprachiasmatic nucleus (SCN) is thought to drive daily rhythms of behavior by secreting factors that act locally within the hypothalamus. In a systematic screen, we identified transforming growth factor-α (TGF-α) as a likely SCN inhibitor of locomotion. TGF-α is expressed rhythmically in the SCN, and when infused into the third ventricle it reversibly inhibited locomotor activity and disrupted circadian sleep-wake cycles. These actions are mediated by epidermal growth factor (EGF) receptors on neurons in the hypothalamic subparaventricular zone. Mice with a hypomorphic EGF receptor mutation exhibited excessive daytime locomotor activity and failed to suppress activity when exposed to light. These results implicate EGF receptor signaling in the daily control of locomotor activity, and identify a neural circuit in the hypothalamus that likely mediates the regulation of behavior both by the SCN and the retina.

  • * Present address: Institute for Medical Immunology, Humboldt University, 10098 Berlin, Germany.

  • These authors contributed equally to this work.

  • To whom correspondence should be addressed. E-mail: cweitz{at}hms.harvard.edu

View Full Text